title: Why is management of cancer pain still a problem?
authors.forename: Martin R
authors.initials: MR
authors.lastname: Stockler
authors.forename: Nicholas R C
authors.initials: NR
authors.lastname: Wilcken
mesh_terms: D000700:Analgesics / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001897:Boronic Acids / Q000008:administration & dosage*; D000069286:Bortezomib; D001943:Breast Neoplasms / Q000188:drug therapy*; D015179:Colorectal Neoplasms / Q000188:drug therapy*; D005260:Female; D054625:Healthcare Disparities; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D009101:Multiple Myeloma / Q000188:drug therapy*; D059408:Pain Management / Q000379:methods*; D010818:Practice Patterns, Physicians'; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D011719:Pyrazines / Q000008:administration & dosage*
chemical_list: D000700:Analgesics; D061067:Antibodies, Monoclonal, Humanized; D001897:Boronic Acids; D011719:Pyrazines; C546027:elotuzumab; D000069286:Bortezomib